David P. Skoner's research while affiliated with West Virginia University and other places

Publications (306)

Article
Introduction Outdoor air pollution (OAP) contributes to poor asthma outcomes and remains a public health concern in Pittsburgh. The purpose of this study was to determine the prevalence of childhood asthma and its rate of control among Pittsburgh schoolchildren residing near OAP sites. Methods Participants were recruited from schools near OAP site...
Article
Background: An Asthma Adherence Pathway (AAP) application, which is an Internet application that combines patient and clinician education strategies to promote adherence to asthma therapy, has been developed. Objective: The primary objective of this pilot study was to evaluate the effectiveness of the AAP application with electronic adherence mo...
Article
Background: Large sample sizes are needed for sublingual immunotherapy (SLIT) trials due to inherent data variability secondary to inconsistent allergen exposure. Obtaining large sample sizes for pediatric SLIT trials is challenging, but a Bayesian approach using prior adult data can reduce the necessary sample size. Objective: To describe how a...
Article
Full-text available
Background: Adults and adolescents were included in 3 phase 3 omalizumab trials in chronic idiopathic urticaria (CIU): ASTERIA I, ASTERIA II, and GLACIAL. Objective: To describe the baseline clinical profile of adolescent patients with CIU enrolled in the omalizumab trials to add to the limited literature available on CIU in this population. Me...
Article
Background: Both slowed growth in children and reduced bone mineral density (BMD) are systemic effects of corticosteroids, and there is concern about the degree to which these systemic effects affect growth and BMD. Objective: To engage in a data-driven discussion of the effects of inhaled corticosteroids (ICSs) on growth in children and BMD. M...
Article
Background: Earlier 1-year growth studies that used older inhaled corticosteroid (ICS) formulations consistently showed that ICS, but not intranasal corticosteroids (INCS), produced a small 1 cm/y growth effect that appeared to be nonprogressive and noncumulative. Studies that lasted for 1 year showed that such treatment during childhood did not a...
Article
Sublingual immunotherapy (SLIT) is a safe and effective treatment for allergic rhinitis (AR) and allergic rhinoconjunctivitis (ARC). The Food and Drug Administration (FDA) in the USA has approved three SLIT tablets for the treatment of AR and ARC in relation to pollen. Specifically, Grastek® and Oralair® are two formulations approved to treat patie...
Article
To identify the prevalence of asthma, obesity, hypertension, and environmental tobacco smoke (ETS) exposure among youth and provide recommendations for follow-up care. This cross-sectional study consisted of 12 health screenings for children between 5 and 17 years of age in various inner city, lower socioeconomic, and predominantly black communitie...
Article
Chronic rhinosinusitis (CRS) and asthma frequently coexist in children and adults. However, the precise pathophysiologic mechanism of this interaction is still poorly understood, especially in children, owing to the lack of direct measurements of mucosal inflammation in the upper airways. To determine the pathophysiologic mechanism by analyzing the...
Article
Inadequate designs and conflicting results from previous studies prompted the US Food and Drug Administration to publish guidelines for the design of clinical trials evaluating the effects of orally inhaled and intranasal corticosteroids on the growth of children. This study conformed to these guidelines to evaluate the effect of triamcinolone acet...
Article
Full-text available
Objective: To evaluate the effectiveness of asthma education delivered by student pharmacists and to assess the impact of child and caregiver baseline asthma knowledge on asthma control in children. Design: Student pharmacists developed and implemented asthma self-management education interventions for children and their caregivers and performed...
Article
Background Patients with asthma may be more susceptible to adverse events (AEs) with sublingual immunotherapy tablet (SLIT-tablet) treatment, such as severe systemic reactions and asthma-related events. Using data from 8 trials of grass SLIT-tablet in subjects with allergic rhinitis with/without conjunctivitis (AR/C), AE frequencies were determined...
Article
Background The practices and beliefs of the provider specialties that treat allergic rhinoconjunctivitis (ARC) with allergen immunotherapy (AIT) may vary.MethodsA telephone survey of 500 randomly selected health care practitioners in 7 specialties, conducted in 2012.ResultsAIT was provided as a subcutaneous injection (SCIT) by 91% of allergist/immu...
Article
Purpose of review: Sublingual immunotherapy (SLIT) is indicated for the use in pediatric patients suffering from allergic rhinitis or allergic rhinoconjunctivitis caused by environmental allergens, such as ragweed pollen, grass pollen, and dust mite. This review focuses on recent and relevant studies associated with the use of SLIT for these aller...
Article
The effect of cetirizine on quality of life (QOL) in subjects with perennial allergic rhinitis (PAR) has been previously evaluated using generic instruments. While generic QOL tools are used across various conditions, disease-specific instruments evaluate the impact of treatment on areas that are affected by that COPY particular condition. This stu...
Article
Previous nationwide surveys of allergies in the United States have focused on nasal symptoms, but ocular symptoms are also relevant. This study determines the effects of ocular and nasal allergies on patients' lives. Telephone surveys of randomly selected U.S. households (the patient survey) and health care providers (provider survey) were conducte...
Article
Background The bronchodilatory effect of mometasone furoate/formoterol fumarate (MF/F) administered by metered-dose inhaler (MDI) with or without a spacer has not been evaluated previously in children aged 5-11 years. Methods This was a randomized, multicenter, placebo-controlled, single-dose, four-period crossover study. Children with persistent a...
Article
Allergen immunotherapy (AIT) is used for the treatment of allergic rhinoconjunctivitis as a subcutaneous injection (subcutaneous immunotherapy [SCIT]). Extracts used for SCIT are also used off-label to formulate a liquid delivered as sublingual drops (sublingual immunotherapy [SLIT]). This study was designed to survey patients' experiences and beli...
Article
Full-text available
Allergic rhinoconjunctivitis (ARC) is managed by a number of health care professional specialties, whose practice styles may vary. To survey patients and health care professionals about the diagnosis and treatment of ARC. The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys were telephone surveys of randomly selected patients and he...
Article
Allergic diseases are common in pediatrics and can be caused by seasonal pollens, specifically grass, trees, and weeds. In many European countries, sublingual immunotherapy (SLIT) is an accepted form of treatment for allergic rhinitis. However, the Food and Drug Administration (FDA) has not yet approved its use in the United States. This review foc...
Article
In North America, few studies have evaluated sublingual immunotherapy for allergic rhinitis with or without conjunctivitis (AR/C); pediatric data are sparse. The authors report findings from the largest published immunotherapy trial yet conducted in adults and children. To evaluate grass sublingual immunotherapy tablet (MK-7243) treatment in subjec...
Article
Background: The prevalence of asthma and obesity in children has increased over the past several years, with obesity being associated with higher rates of asthma. In response to known disparities in asthma prevalence and morbidity, along with barriers to diagnosis, assessment and education, a comprehensive asthma sports camp series was developed a...
Article
Inhaled corticosteroids (ICSs) are an effective therapy for the treatment of persistent asthma of all severities because they reduce symptoms, improve lung function, and reduce underlying inflammation. Although ICSs are generally safe for long- term use, there is concern among physicians and patients about potential systemic side effects, including...
Article
Background Allergic rhinitis (AR) is a common pediatric problem that significantly affects sleep, learning, performance, and quality of life. In addition, it is associated with significant comorbidities and complications. Objective The aim was to provide an update on the epidemiology, comorbidities, pathophysiology, current treatment, and future d...
Article
To assess the effects of long-term mometasone furoate delivered via a dry powder inhaler (MF-DPI) on growth velocity and hypothalamic-pituitary-adrenal axis function in children with asthma. Children aged 4-9 years with asthma (n = 187) were randomized to MF-DPI 100 μg (delivered dose; actuated dose is 110 μg) once daily in the morning (QD AM), 100...
Article
Sublingual immunotherapy (SLIT) is a well-established treatment option for allergic rhinitis in several European countries, but it is considered investigational in the United States. Studies conducted in Europe provided a large body of evidence supporting the safety and efficacy of SLIT, but those studies used allergen products that are different f...
Article
Full-text available
Evidence supports a bidirectional relationship between stress and asthma exacerbations in children, suggesting that interventions to reduce stress may improve both psychosocial quality of life and disease course. Here, we examine the feasibility of a stress management intervention for 7- to 12-year-olds with asthma. Two trials were conducted. Cohor...
Article
Allergy immunotherapy tablet (AIT) treatment might be a safe and convenient form of specific immunotherapy but it has not been investigated in North American children and adolescents. We sought to investigate the efficacy and safety of timothy grass AIT treatment in North American children/adolescents with grass pollen-induced allergic rhinoconjunc...
Article
Small-particle inhaled corticosteroid (ICS) metered-dose inhalers were recently developed to treat asthma as part of the CFC to HFA propellant switch mandated by the Montreal Protocol. Two such ICS, beclomethasone dipropionate (BDP) and ciclesonide (CIC), are available in the United States and are formulated in HFA solutions. A major advantage of s...
Article
Specific allergen immunotherapy is most often delivered subcutaneously, but sublingual immunotherapy may confer greater benefit in terms of tolerability and safety, accessibility, and improved antigen delivery. This randomized, double-blind, placebo-controlled trial was conducted to identify a safe and effective maintenance dose range of sublingual...
Article
Corticosteroids are the foundation of pharmacologic treatment for children with asthma. However, high-dose inhaled corticosteroid treatment can cause hypothalamic-pituitary-adrenal (HPA) axis suppression. We investigated the effect of three doses of mometasone furoate administered via dry-powder inhaler (MF-DPI) on the HPA axis in children. Fifty c...
Article
Otitis media (OM) is a common and costly medical condition, especially in children. Most episodes of OM are associated with an upper respiratory viral infection and are short-lived and self-limiting with or without medical treatment. However, chronic OM with effusion (OME) has significant sequelae, is refractory to most medical treatments, and freq...
Article
Inhaled corticosteroids are used widely to treat asthma. A number of different steroids and inhalation devices are available. The pharmacokinetic and pharmacodynamic properties of the different inhaled corticosteroids may influence their efficacy and safety profiles. Properties of an ideal inhaled corticosteroid include low oropharyngeal deposition...
Article
Inhaled corticosteroids (ICS) are the guideline-preferred preventative therapy for persistent asthma of all severity levels and for all ages, including children. While these drugs are unquestionably efficacious, concerns of adverse systemic effects limit patient compliance with treatment regimens and thus the attainable benefits. Suppression of bon...
Chapter
Otitis media (OM) and sinusitis are common and costly maladies that are often preceded by the development of a viral upper respiratory infection (vURI). Although antibiotics have been shown to be somewhat effective in the treatment of these disorders, increasing concern over the emergence of pathogen resistence to these agents underscores the need...
Article
Full-text available
Ciclesonide is a novel inhaled corticosteroid used in the continuous treatment of mild-to-severe asthma. Its formulation and mechanism of action yield a low oral and systemic bioavailability, and high pulmonary deposition. In multiple clinical trials, ciclesonide is at least as effective as either fluticasone propionate or budesonide at symptom con...
Article
Results: Of 117 children assigned to the OT group, 100 completed follow-up; of 115 assigned to the OT with a prescription group, 106 completed follow-up. In the OT group, 87 parents reported no antibiotic use within the 3-day observation period, compared with 66 parents in the prescription group. During the entire study period, 81% of the OT group...
Article
Guidelines recommend treatment with intranasal corticosteroids for patients with allergic rhinitis (AR), but concerns remain about possible adverse effects. To present the 1- and 2-year growth results for children with AR treated with triamcinolone acetonide aqueous nasal spray. Thirty-nine children (aged 6.1-14.3 years at study entry) were treated...
Article
This study assessed the efficacy and safety of guaifenesin 600 mg and pseudoephedrine hydrochloride 60 mg extended-release bilayer tablets in providing relief of acute respiratory symptoms when used as an adjunct to antibiotics in patients with an acute respiratory infection (ARI). Adult patients experiencing symptoms of ARI and meeting the physici...
Article
Inhaled corticosteroids (ICSs) are the preferred first-line preventative therapy for asthma of all severity levels. Although these drugs have been proven efficacious, concerns of adverse systemic affects due to both long- and short-term use continue to limit patient compliance with dosing regimens. Deficits in bone growth, bone density, and hypotha...
Article
Full-text available
To assess the effects of the new inhaled corticosteroid ciclesonide on growth in children with asthma. We performed a multicenter, randomized, double-blind, placebo-controlled study to assess the effects of inhaled ciclesonide on growth in children with mild, persistent asthma. After a 6-month run-in period, 661 prepubertal children who were aged 5...
Article
Antihistamines are used frequently in adult and pediatric patients as first-line treatment for both allergic rhinitis and urticaria. There are several different antihistamines on the market, generally divided into first- and second-generation products. Although many of these show efficacy, there are significant differences in the side effect profil...
Article
OBJECTIVE: To assess the effects of the new inhaled corticosteroid ciclesonide on growth in children with asthma. METHODS: We performed a multicenter, randomized, double-blind, placebo-controlled study to assess the effects of inhaled ciclesonide on growth in children with mild, persistent asthma. After a 6-month run-in period, 661 prepubertal chil...
Article
PURPOSE: Assessing systemic effects that inhaled corticosteroids may exert in children with asthma is of great importance. We report findings from a pediatric study investigating the effects of mometasone furoate dry-powder inhaler (MF-DPI) on the hypothalamic-pituitary-adrenal axis. Unlike previously published investigations in children, systemic...

Citations

... First, although most studies did not identify substantial effects of inhaled corticosteroids on linear growth or the hypothalamic-pituitary-axis, investigators and clinicians remain concerned about this potential phenomenon and highlight a need for more prolonged evaluations, particularly at critical times of pediatric growth and development. [13][14][15][16][17][18] Second, proton pump inhibitors have been associated with gastric hyperplasia among those with long-term use, and existing evaluations in children are considered inadequate to rule out this adverse event. [19][20][21] Third, short-term and longer-term evaluations of stimulants have been associated with insomnia, concern for abnormal cognitive development, and impaired growth; quantification of risks are not fully elucidated. ...
... OM is often associated with preceding or concurrent viral upper respiratory tract infection, such as those caused by parainfluenza virus [9], influenza virus [10,11,12], rhinovirus [13], adenovirus [14] and respiratory syncytial virus (RSV) [9,13]. Infection by upper respiratory tract viruses results in dysregulation of normal Eustachian tube (ET) function via decreased mucociliary action, altered mucus secretion by goblet cells and increased expression of inflammatory mediators of the host [15,16,17], among other mechanisms. ...
... Allergen immunotherapy (AIT) is the only treatment of allergy capable of modulating the inflammatory T cell response, inducing allergen-specific regulatory T cells, and activating B cells to produce allergen-specific IgG blocking antibodies [1][2][3] . To reduce the risk of IgE mediated side effects associated with allergen extracts during AIT [4] , recombinant-based formulations containing hypoallergens have been developed as candidates in the treatment of pollen allergy [5]. Therefore, it is essential to carefully select and standardise these candidate molecules. ...
... The potency of ICS is significantly influenced by receptor affinity. However, a greater receptor affinity is not always an advantage, as this is often correlated with greater toxicity [13]. In conclusion, a higher therapeutic index of ICS (therapeutic index = TD50 (toxic dose)/ED50 (effective dose), as reported for ciclesonide, fluticasone furoate, fluticasone propionate and mometasone furoate, is associated with greater potency, drug-target residence time, systemic clearance and low oral bioavailability [12]. ...
... Moreover, several systematic reviews supported the specific use of SLIT in the treatment of AR in children, as well as the EAACI position paper on pediatric rhinitis did. Recent analyses inferred a moderate strength and general evidence that SLIT improves pediatric AR and conjunctivitis, ameliorating symptoms and/or decreasing the drug consumption [12,[91][92][93] . This evidence resulted to be stronger for grass pollen SLIT in the treatment of isolated AR, whereas the evidence for house dust mite SLIT effectiveness is still considered "of moderate-low quality", as resulted from few available randomized controlled trials. ...
... Adenoidectomy is the first-line surgical intervention for younger children with signs of PCRS with success rates ranging between 47% and 58% of cases [86] and revision rates being as low as 1.9% [87]. Adenoids act as a reservoir for bacteria in children with PCRS or might cause anatomic obstruction and thus resecting this tissue improves outcomes [2,88,89]. A study reported significant improvements in symptom severity scores in children with PCRS at six months from the date of undergoing an adenoidectomy [90]. ...
... Chronic urticaria (CU) is defined as presence of pruritic wheals, angioedema or both occurring on most days of the week and persisting for at least 6 weeks. 1 Recent evidence suggests that CU in children may be as frequent as in adults with point prevalence estimates of 0.5%-1.5% affecting males and females equally. [2][3][4][5][6] Approximately 20% of CU cases have a proven physical/inducible trigger and are known as chronic inducible urticaria (CIndU), 6 while in the remaining cases, hives occur spontaneously and are known as chronic spontaneous urticaria (CSU) (historically referred to as chronic idiopathic urticaria). 7 The clinical manifestations of pruritus, hives and angioedema are direct consequences of mast cell degranulation and release of preformed or newly synthetized inflammatory/ vasoactive mediators (e.g., histamine, platelet-activating factor, cytokines) and neuropeptides. ...
... Additionally, adverse reactions caused by intranasal steroid sprays. Systemic reactions included systemic allergic reaction (anaphylaxis), 21 and systemic adverse reactions of pharmacological therapy. The difference between Medication scores: medication scores were considered at the beginning and the end of the study. ...
... Studies show that different spacer devices increase the bioavailability of inhaled medication 31,32 . However, the fundamental issue for the delivery of the medication is an adequate technique 33,34 . ...
... 197,198 In a small, nonrandomized, open-label study, children were followed for 2 years while receiving triamcinolone acetonide nasal spray, and their height was measured by stadiometry and compared with predicted values; no significant difference was shown between measured and predicted heights. 199 Therefore, in clinical practice, it seems prudent to use the intranasal steroid preparations that have not been shown to have any negative impact on growth in children, as detailed above. ...